SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3042% above fair value
$23.54+0.38 (+1.64%)
Close on Nov 18, 2026Market cap $1.06BP/E –Yield 0.00%
Si-Bone operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Si-Bone's operating cash flow for the twelve months ending Jun 30, 2026 was $2.48M. For fiscal 2025 it was -$675.00K. The highest annual figure on record is -$675.00K in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$675.00K | – |
| FY2024 | Dec 31, 2024 | -$12.43M | – |
| FY2023 | Dec 31, 2023 | -$18.71M | – |
| FY2022 | Dec 31, 2022 | -$41.66M | – |
| FY2021 | Dec 31, 2021 | -$39.53M | – |
| FY2020 | Dec 31, 2020 | -$30.66M | – |
| FY2019 | Dec 31, 2019 | -$31.63M | – |
| FY2018 | Dec 31, 2018 | -$14.52M | – |
| FY2017 | Dec 31, 2017 | -$17.53M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $777.00K | +349.1% |
| Q1 FY2026 | Mar 31, 2026 | -$2.36M | – |
| Q4 FY2025 | Dec 31, 2025 | $1.73M | +46.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.34M | +673.2% |
| Q2 FY2025 | Jun 30, 2025 | $173.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.91M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.18M | – |
| Q3 FY2024 | Sep 30, 2024 | $302.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.30M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.07M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.75M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.78M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.51M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.71M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.31M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.15M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.36M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.88M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.03M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.12M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.08M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.32M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.53M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.26M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.41M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.04M | – |
See a number that looks wrong?